CAC Software vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by Prolaio

AI Verdict

Tool A quantifies coronary artery calcification from CT scans to assess cardiovascular disease risk, providing anatomical insights. In contrast, Tool B estimates peak oxygen consumption using wearable sensor data for functional cardiovascular assessment and research. While both are cardiology AI tools, they leverage different data modalities and address distinct aspects of heart health.

Choose CAC Software if…

Choose Imbio CAC Software if your primary objective is to quantify coronary artery calcification from existing non-contrast chest CT scans to assess a patient's risk for coronary artery disease. This tool is ideal for radiologists and cardiologists seeking automated, deep-learning based analysis to generate Agatston scores, arterial age, and 3D visualizations for comprehensive risk stratification.

View CAC Software →

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if you need to estimate peak oxygen consumption (eVO2peak) to evaluate a patient's functional capacity and cardiovascular fitness using real-world data from wearable medical sensors. This software is best suited for cardiologists, physical medicine, and sports medicine specialists looking for an adjunctive aid in clinical evaluation and high-density, longitudinal monitoring of cardiovascular health.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software prolaio eVO2peak Module
Pricing Unknown Contact for pricing
Deployment Cloud-based (SaaS), integrates with PACS Cloud-based (software-only, processes remote sensor data)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool A (CAC Software) integrates seamlessly into existing radiology DICOM viewing workflows, operating automatically without user intervention for analysis. Its outputs are directly inserted into the patient study, enhancing clinical efficiency. Tool B (prolaio eVO2peak Module) requires patient engagement with wearable devices and a mobile app for data collection, which, while valuable, introduces more steps for the patient compared to Tool A's clinician-centric automation.

Clinical Value

Tie

Both tools offer significant and validated clinical value in cardiology. Tool A provides automated quantification of coronary artery calcification (CAC score), a well-established biomarker for cardiovascular risk assessment, with a Cohen's kappa of 0.907 in validation. Tool B innovatively estimates peak oxygen consumption (eVO2peak) from real-world wearable data, a crucial functional capacity metric, and has met target accuracy and reliability criteria in clinical studies.

Pricing & Value

Tie

Neither Tool A nor Tool B provides transparent pricing information, both requiring direct contact for quotes. Without specific pricing details, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

CAC Software

Tool A (CAC Software) offers superior enterprise readiness with flexible deployment options including cloud, on-premise, and integration via partner platforms. This adaptability allows it to fit diverse IT infrastructures and security requirements within healthcare organizations. Tool B (prolaio eVO2peak Module) is solely cloud-based and relies on qualified third-party wearable sensors, which may present more integration complexities for some enterprises.

Innovation

prolaio eVO2peak Module

Tool B (prolaio eVO2peak Module) demonstrates greater innovation by leveraging real-world data from wearable sensors and deep learning to estimate eVO2peak, enabling continuous and longitudinal physiological monitoring outside traditional clinical settings. This approach represents a novel application of AI for health data collection and analysis. While Tool A automates an important diagnostic process, Tool B's methodology is a more significant departure from conventional assessment methods.

Support & Docs

CAC Software

Tool A (CAC Software) provides comprehensive support information, including specific phone numbers for US and India, email, online case submission, and defined support hours (8:00 AM u2013 6:00 PM CST). User manuals and FAQs are also explicitly mentioned as available. Tool B (prolaio eVO2peak Module) mentions 'always-on support' and an email contact, but lacks the detailed and structured support information provided by Tool A.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software prolaio eVO2peak Module
Tool Name CAC Software prolaio eVO2peak Module
Company Imbio Prolaio
Primary Function/Purpose Automated image post-processing to determine location and calculate calcification in coronary arteries from non-contrast chest CT. Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.
Input Data/Modality Non-contrast, chest computed tomography (CT) Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors
Key Output/Metric Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images Estimated peak oxygen consumption (eVO2peak)
Categories Cardiology AI Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Radiology Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring CAC Software and prolaio eVO2peak Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software performs automated image post-processing on non-contrast chest computed tomography (CT) scans. Prolaio's eVO2peak Module estimates peak oxygen consumption using demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images, to support risk assessment for coronary artery disease. Prolaio's eVO2peak Module provides an estimation of peak oxygen consumption (eVO2peak) as an adjunctive aid in clinical evaluation for cardiovascular research and care.
Imbio's CAC Software is designed to help radiologists and cardiologists determine and quantify coronary artery calcification for risk assessment of coronary artery disease. Prolaio's eVO2peak Module is developed to estimate peak oxygen consumption for cardiovascular research and care, enabling high-density, longitudinal data collection.
Imbio's CAC Software is primarily relevant to Cardiology and Radiology due to its reliance on CT imaging analysis. Prolaio's eVO2peak Module extends its relevance to Cardiology, Physical Medicine & Rehab, and Sports Medicine, given its focus on estimating functional capacity from wearable sensor data.
Imbio's CAC Software uses deep-learning based automated image post-processing algorithms to analyze static CT images for calcification. Prolaio's eVO2peak Module applies a locked deep-learning model and proprietary algorithms to process dynamic real-world patient data from remote wearable sensors.
AI Tool Finder
AI-powered search. Results may not be comprehensive.